Cargando…
The clinical impact of serum 1,5-anhydro-D-glucitol levels on coronary artery calcification and adverse outcomes assessed by coronary optical coherence tomography in diabetic patients
BACKGROUND: Serum 1,5-anhydro-D-glucitol (1,5-AG) is a novel biomarker for short-term glycemic status and postprandial hyperglycemia. The association between serum 1,5-AG levels and coronary artery calcification (CAC) through a quantitative assessment using optical coherence tomography (OCT) is uncl...
Autores principales: | Teng, Hsin-I, Chen, Hsiang-Yao, Tsai, Chuan-Tsai, Huang, Wei-Chieh, Chen, Ying-Ying, Hsueh, Chien-Hung, Hau, William K., Lu, Tse-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468365/ https://www.ncbi.nlm.nih.gov/pubmed/36110416 http://dx.doi.org/10.3389/fcvm.2022.997649 |
Ejemplares similares
-
Impact of serum 1,5-anhydro-d-glucitol level on the prediction of severe coronary artery calcification: an intravascular ultrasound study
por: Wada, Hideki, et al.
Publicado: (2019) -
The Application of Plasma 1,5-Anhydro-D-glucitol for Monitoring Type 2 Diabetic Patients
por: Dworacka, Marzena, et al.
Publicado: (2005) -
Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes
por: Torimoto, Keiichi, et al.
Publicado: (2014) -
Association of time in range with hemoglobin A1c, glycated albumin and 1,5‐anhydro‐d‐glucitol
por: Ohigashi, Mana, et al.
Publicado: (2020) -
1,5-Anhydro-D-Glucitol Could Reflect Hypoglycemia Risk in Patients with Type 2 Diabetes Receiving Insulin Therapy
por: Kim, Min Kyeong, et al.
Publicado: (2016)